Fujita Corp <3370>: 294 yen (+74 yen)

Temporarily hit the upper limit. A new Shareholder benefit system has been announced. As of the end of March, shareholders holding more than 100 shares will receive a 1,000 yen web coupon. The purpose of the new benefit is to deepen understanding of the business by engaging with the company's products and services, enhance the appeal of investing in Stocks, and encourage many investors to hold shares long-term. There is a movement to expect an expansion of the investor base.

Fujita HD <4676>: 1839.5 yen (+104 yen)

Significant continued rise. Nomura Securities has upgraded its investment determination from 'neutral' to 'buy', and has also raised the Target Price from 2,010 yen to 2,420 yen. The company has the highest revenue ratio from non-terrestrial advertising among the five broadcasting stations and is believed to be less affected by the revenue decline in the terrestrial advertising business in the medium term. It is determined that the current share price does not sufficiently reflect the profit expansion accompanying the revenue growth of the non-terrestrial advertising business. The announcement of quantitative targets for Share Buyback is also noted as a point of interest going forward.

Toho Lead <5707>: 592 yen (-148 yen)

Temporarily hit the lower limit. The announcement states that a third-party allotment capital increase involving investment fund Advantage Partners and others will raise a total of 7.5 billion yen. Financial health has worsened due to market fluctuations and high-cost mining operations, and besides improving the financial base through capital increase, there seems to be a plan to reorganize unprofitable businesses such as the withdrawal from resource operations and encourage voluntary retirement. The potential dilution of voting rights is expected to be about 299.8%, leading to negative perceptions.

AndDo <3457>: 1116 yen (+150 yen)

Upper limit hit. A capital and business alliance with Dai-ichi Life HD has been announced. Dai-ichi Life HD is expected to hold a 15.73% investment ratio through a third-party allotment capital increase resulting from the disposal of its own shares, thereby applying the equity method. The amount of investment is undisclosed but is believed to be in the tens of billions of yen. To facilitate the disposal of its own shares, the company will implement a Share Buyback limited to 1.05 million shares, equivalent to 5.29% of the outstanding shares, with a maximum of 1.4 billion yen.

Heiwa <6412>: 2439 yen (+297 yen)

Significant rebound. It was announced that the largest domestic golf course operator, Accordia Golf, would be acquired for 510 billion yen. The parent company's shares will be acquired from the U.S. investment fund Fortress. Funding for the acquisition will be completely financed through loans from the Bank, with stock acquisition expected by the end of January 2025. Together with its subsidiaries, it is expected to become one of the largest golf course companies in the world. If the financial performance is simply aggregated, revenue and operating profit will be about double the current level. There are concerns about the financial burden, but movements to evaluate business expansion have led the way.

Kaiomu <4583>: 271 yen (-10 yen)

The price fell. After the close of trade on the 18th, it was announced that the contract period of the basic agreement for commissioned research with Chugai Pharmaceutical was extended, but the unfavorable market conditions led to a prevailing selling pressure. The company signed a memorandum of changes to the basic agreement for commissioned research with Chugai Pharmaceutical, further extending the contract period specified in the original contract dated June 30, 2011 (previous extension disclosed on October 18, 2021, until December 31, 2024).

Kusuri no Madoguchi <5592>: 1465 yen (+103 yen)

Continuing to rise. For the fiscal year ending March 2025, revenue estimates have been revised upwards from 10 billion yen to 10.5 billion yen (5.0% increase), and recurring profit has been revised upwards from 1.485 billion yen to 1.634 billion yen (10.0% increase). The additional introduction of products with online medication guidance from the Broadcasting business and the addition of subsidized functional features in the core system business have led to increased customer demand, resulting in revenue expected to exceed the initial forecast. Additionally, the year-end lump-sum dividend has been increased from the previously planned 14 yen to 15.4 yen (no dividends in the previous term).

Astroscale <186A>: 766 yen (-17 yen)

Started with buying but couldn't maintain gains and fell back. It has been announced that the transition to Phase 2 for the ISSA mission, ISSA-J1, has been decided. ISSA-J1 is an imaging and diagnostic mission focused on large satellites and targeted debris in the vicinity. The project is divided into three business phases with the business period expected to last until March 2028. In Phase 1, the basic design review (PDR) as a preparatory stage for Phase 2 and beyond has been carried out and completed as scheduled. In Phase 2, detailed design, satellite assembly, ground testing, operational preparations, etc., are planned.